Is ignorance bliss? Depression, antidepressants, and the diagnosis of prediabetes and type 2 Diabetes

Health Psychology

Volumn 32, Issue 3, 2013, Pages 254-263

  Mezuk, Briana ^a   Johnson Lawrence, Vicki ^b   Lee, Hedwig ^c   Rafferty, Jane A ^b   Abdou, Cleopatra M ^d   Uzogara, Ekeoma E ^b   Jackson, James S ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antidepressants; Comorbidity; Coping; Depression; Diabetes

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; INSULIN; METFORMIN; MONOAMINE OXIDASE INHIBITOR; ORAL ANTIDIABETIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR CHANGE; CORRELATION ANALYSIS; DEPRESSION; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG UTILIZATION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT HEALTH QUESTIONNAIRE 9; PHYSICAL ACTIVITY; RISK FACTOR; SMOKING; WEIGHT REDUCTION;

ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; UNITED STATES;

EID: 84881092831     PISSN: 02786133     EISSN: 19307810     Source Type: Journal    
DOI: 10.1037/a0029014     Document Type: Article

References (48)

1. American Diabetes Association. (2010). Standards of medical care in diabetes - 2010. Diabetes Care, 33, S11-S61. doi:10.2337/dc10-S011
2. Benjet, C., Wagner, F. A., Borges, G. G., & Medina-Mora, M. E. (2004). The relationship of tobacco smoking with depressive symptomology in the third Mexican American Additions Survey. Psychological Medicine, 34, 881-888. doi:10.1017/S0033291703001600
3. Bennett, K. K., & Elliott, M. (2005). Pessimistic explanatory style and cardiac health: What is the relation and the mechanism that links them? Basic and Applied Social Psychology, 27, 239-248. doi:10.1207/s15324834basp2703_5
4. Berkson, J. (1946). Limitations of the application of fourfold table analysis to hospital data. Biometrics Bulletin, 2, 47-53. doi:10.2307/3002000
5. Breslin, M., Millan, R. J., & Montori, V. M. (2008). The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes. Patient Education and Counseling, 73, 465-472. doi:10.1016/j.pec.2008.07.024
6. Campayo, A., de Jonge, P., Roy, J. F., Saz, P., de la Camara, C., Quintanilla, M. A., . . . Lobo, A. (2010). Depressive disorder and incident diabetes mellitus: The effect of characteristics of depression. The American Journal of Psychiatry, 167, 580-588. doi:10.1176/appi.ajp.2009.09010038
7. Centers for Disease Control. (2004). NHANES 2001-2002, 2003-2004, and 2005-2006 documentation. Date retrieved: January 10, 2010. Available from: http://www.cdc.gov/nchs.htm.
8. Champaneri, S., Wand, G. S., Malhotra, S. S., Casagrande, S. S., & Golden, S. H. (2010). Biological basis of depression in adults with diabetes. Current Diabetes Reports, 10, 396-405. doi:10.1007/s11892-010-0148-9
9. Dallman, M. F., Pecoraro, N., Akana, S. F., La Fleur, S. E., Gomez, F., Houshyar, H., . . . Manalo, S. (2003). Chronic stress and obesity: A new view of "comfort food." Proceedings of the National Academy of Sciences of the United States of America, 100, 11696-11701.
10. de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001). Association of depression and diabetes complications: A meta-analysis. Psychosomatic Medicine, 63, 619-630.
11. Diabetes Prevention Program. (1999). Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care, 22, 623-634. doi:10.2337/diacare.22.4.623
12. Duangdao, K. M., & Roesch, S. (2008). Coping with diabetes in adulthood: A meta-analysis. Journal of Behavioral Medicine, 31, 291-300. doi: 10.1007/s10865-008-9155-6
13. Eaton, W. W., Hall, A. L. F., MacDonald, R., & McKibben, J. (2007). Case identification in psychiatric epidemiology: A review. International Review of Psychiatry, 19, 497-507. doi:10.1080/09540260701564906
14. Golden, S. H., Lazo, M., Carnethon, M., Bertoni, A. G., Schreiner, P. J., Diez Roux, A. V., . . . Lyketsos, C. (2008). Examining a bidirectional association between depressive symptoms and diabetes. JAMA: Journal of the American Medical Association, 299, 2751-2759. doi:10.1001/jama.299.23.2751
15. Golden, S. H., & Mezuk, B. (2009). The association of depressive symptoms with prediabetes versus diagnosed diabetes: Is ignorance bliss? Physician and Sportsmedicine, 37, 143-145. doi:10.3810/PSM.2009.04.1697
16. Golding, J. M., Burnam, M. A., Wells, K. B., and Benjamin, B. (1993). Alcohol use, depressive symptoms, and cultural characteristics in two Mexican-American samples. International Journal of the Addictions, 28, 451-476.
17. Goodman, E., & Huang, B. (2002). Socioeconomic status, depressive symptoms, and adolescent substance use. Archives of Pediatrics and Adolescent Medicine, 156, 448-453.
18. Hamer, M., Batty, D. G., Stamatakis, E., and Kivimaki, M. (2010). Hypertension awareness and psychological distress. Hypertension, 56, 547-550. doi:10.1161/HYPERTENSIONAHA.110.153775
19. Hasin, D. S., Stinson, F. S., Ogburn, E., and Grant, B. F. (2007). Prevalence, correlates, disability and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64, 830-842. doi:10.1001/archpsyc.64.7.830
20. Holt, R. I. G., Phillips, D. I. W., Jameson, K. A., Cooper, C., Dennison, E. M., & Peveler, R. C. (2009). The relationship between depression and diabetes mellitus: Findings from the Hertfordshire Cohort Study. Diabetic Medicine, 26, 641-648. doi:10.1111/j.1464-5491.2009.02742.x
21. Jackson, J. S., Knight, K. M., & Rafferty, J. A. (2010). Race and unhealthy behaviors: Chronic stress, the HPA axis, and physical and mental health disparities over the life course. American Journal of Public Health, 100, 933-939. doi:10.2105/AJPH.2008.143446
22. John, U., Meyer, C., Rumpf, H. J., and Hapke, U. (2004). Smoking, nicotine dependence, and psychiatric comorbidity: A population-based study including smoking cessation after three years. Drug and Alcohol Dependence, 76, 287-295. doi:10.1016/j.drugalcdep.2004.06.004
23. Katon, W. J., Lin, E. H., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, B., . . . McCulloch, D. (2010). Collaborative care for patients with depression and chronic illnesses. The New England Journal of Medicine, 363, 2611-2620. doi:10.1056/NEJMoa1003955
24. Kivimäki, M., Batty, G. D., Jokela, M., Ebmeier, K. P., Vahtera, J., Virtanen, M., . . . Hamer, M. (2011). Antidepressant medication use and risk of hyperglycaemia and diabetes mellitus: A non-causal association? Biological Psychiatry, 70, 978-984. doi:10.1016/j.biopsych.2011.07.008
25. Kivimäki, M., Hamer, M., Batty, G. D., Geddes, J. R., Tabak, A. G., Pentti, J., . . . Vahtera, J. (2010a). Antidepressant medication use, weight gain, and risk of type 2 diabetes: A population-based study. Diabetes Care, 33, 2611-2616. doi:10.2337/dc10-1187
26. Kivimäki, M., Tabak, A. G., Lawlor, D. A., Batty, G. D., Singh-Manoux, A., Jokela, M., . . . Vahtera, J. (2010b). Antidepressant use before and after the diagnosis of type 2 diabetes: A longitudinal modeling study. Diabetes Care, 33, 1471-1476. doi:10.2337/dc09-2359
27. Kroenke, K., Spitzer, R. L., Williams, J. B., & Lowe, B. (2010). The patient health questionnaire somatic, anxiety, and depressive symptom scales: A systematic review. General Hospital Psychiatry, 32, 345-359. doi:10.1016/j.genhosppsych.2010.03.006
28. Kroenke, K., Spitzer, R. L., and Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606-613. doi:10.1046/j.1525-1497.2001.016009606.x
29. Lustman, P. J., Clouse, R. E., Nix, B. D., Freedland, K. E., Rubin, E. H., McGill, J. B., . . . Hirsch, I. B. (2006). Sertaline for prevention of depression recurrence in diabetes mellitus: A randomized, double-blind, placebo-controlled trial. Archives of General Psychiatry, 63, 521-529. doi:10.1001/archpsyc.63.5.521
30. Lustman, P. J., Freedland, K. E., Griffith, L. S., & Clouse, R. E. (2000). Fluoxetine for depression in diabetes: A randomized, double-blind, placebo-controlled trial. Diabetes Care, 23, 618-623. doi:10.2337/diacare.23.5.618
31. Macrodimitris, S. D., and Endler, N. S. (2001). Coping, control, and adjustment in type 2 diabetes. Health Psychology, 20, 208-216. doi:10.1037/0278-6133.20.3.208
32. Mäntyselkä, P., Korniloff, K., Saaristo, T., Koponen, H., Eriksson, J., Puolijoki, H., . . . Vanhala, M. (2011). Association of depressive symptoms with impaired glucose regulation, screen-detected, and previously known type 2 diabetes. Diabetes Care, 34, 71-76. doi:10.2337/dc10-1044
33. Markowitz, S. M., Gonzalez, J. S., Wilkinson, J. L., and Safren, S. A. (2011). Treating depression in diabetes: Emerging findings. Psychosomatics, 52, 1-18. doi:10.1016/j.psym.2010.11.007
34. Meier, M., Berchtold, A., Akré, C., Michaud, P. A., and Surís, J. C. (2010). Who eats healthily? A population-based study among young Swiss residents. Public Health Nutrition, 13, 2068-2075. doi:10.1017/S1368980010000947
35. Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008). Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care, 31, 2383-2390. doi:10.2337/dc08-0985
36. Mezuk, B., Rafferty, J. A., Kershaw, K. N., Hudson, D., Abdou, C. M., Lee, H., . . . Jackson, J. S. (2010). Reconsidering the role of social disadvantage in physical and mental health: Stressful life events, health behaviors, race, and depression. American Journal of Epidemiology, 172, 1238-1249. doi:10.1093/aje/kwq283
37. Nouwen, A., Nefs, G., Caramlau, I., Connock, M., Winkley, K., Lloyd, C. E., . . . Pouwer, F. (2011). Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes. Diabetes Care, 34, 752-762. doi:10.2337/dc10-1414
38. Pan, A., Lucas, M., Sun, Q., van Dam, R. M., Franco, O. H., Manson, J. E., . . . Hu, F. B. (2010). Bidirectional association between depression and type 2 diabetes mellitus in women. Archives of Internal Medicine, 170, 1884-1891. doi:10.1001/archinternmed.2010.356
39. Pan, A., Sun, Q., Okereke, O. I., Rexrode, K. M., Rubin, R. R., Lucas, M., . . . Hu, F. B. (2012). Use of antidepressant medication and risk of type 2 diabetes: Results from three cohorts of US adults. Diabetologia, 55, 63-72. doi:10.1007/s00125-011-2268-4
40. Penckofer, S., Ferrans, C. E., Velsor-Friedrich, B., & Savoy, S. (2007). The psychological impact of living with diabetes: Women's day-to-day experiences. The Diabetes Educator, 33, 680-690. doi:10.1177/0145721707304079
41. Rubin, R. R., Knowler, W. C., Ma, Y., Marrero, D. G., Edelstein, S. L., Walker, E. A., . . . Fisher, E. B. (2005). Depression symptoms and antidepressant medicine use in Diabetes Prevention Program participants. Diabetes Care, 28, 830-837. doi:10.2337/diacare.28.4.830
42. Rubin, R. R., Ma, Y., Marrero, D. G., Peyrot, M., Barrett-Connor, E. L., Kahn, S. E., . . . Samore, M. H. (2008). Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the Diabetes Prevention Program. Diabetes Care, 31, 420-426. doi:10.2337/dc07-1827
43. Rubin, R. R., Ma, Y., Peyrot, M., Marrero, D. G., Price, D. W., Barrett-Connor, E., & Knowler, W. C. (2010). Antidepressant medication use and risk of developing diabetes during the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care, 33, 2549-2551. doi:10.2337/dc10-1033
44. Sachs-Ericsson, N., Burns, A. B., Gordon, K. N., Eckel, L. A., Wonderlich, S. A., Crosby, R. D., & Blazer, D. G. (2007). Body mass index and depressive symptoms in older adults: The moderating roles of race, sex and socioeconomic status. The American Journal of Geriatric Psychiatry, 15, 815-825. doi:10.1097/JGP.0b013e3180a725d6
45. Smith, D. E., Heckemeyer, C. M., Kratt, P. P., & Mason, D. A. (1997). Motivational interviewing to improve adherence to a behavioral weightcontrol program for older obese women with NIDDM: A pilot study. Diabetes Care, 20, 52-54. doi:10.2337/diacare.20.1.52
46. Spanou, C., Simpson, S. A., Hood, K., Edwards, A., Cohen, D., Rollnick, S., . . . Butler, C. C. (2010). Preventing disease through opportunistic, rapid engagement by primary care teams using behaviour change counseling (PRE-EMPT): Protocol for a general practice-based cluster randomized trial. BMC Family Practice, 11, doi:10.1186/1471-2296-11-69
47. U.S. Department of Health and Human Services & U.S. Department of Agriculture. (2005). Dietary guidelines for Americans. Date retrieved September 1, 2009. Available at: http://www.health.gov/dietaryguidelines/dga2005/document/pdf/DGA2005.pdf
48. West, D. S., Gore, S. A., DiLillo, V., Greene, P. G., & Bursac, Z. (2007). Motivational interviewing improves weight loss in women with type 2 diabetes. Diabetes Care, 30, 1081-1087. doi:10.2337/dc06-1966